Claims
- 1. Pharmaceutical composition comprising, as active principle, a compound of formula ##STR22## in which R.sub.1 is chosen, from hydrogen, a halogen, a nitro group, a nitroso group, a thiocyano group, a C.sub.1 -C.sub.6 alkyl group, a C.sub.2 -C.sub.6 alkenyl group, an aryl group, an aryl (C.sub.1 -C.sub.6 alkyl) group, an aryl (C.sub.2 -C.sub.6 alkenyl) group, a carboxyl group, a (C.sub.1 -C.sub.6 alkyl) carbonyl group, an arylcarbonyl group, a (C.sub.1 -C.sub.6 alkoxy)carbonyl group, a (C.sub.1 -C.sub.6 alkoxy) carbonyl (C.sub.1 -C.sub.6 alkyl) group, a C.sub.1 -C.sub.6 alkoxy group, a trifluoromethyl group, an amino group, a di (C.sub.1 -C.sub.6 alkyl) amino (C.sub.1 -C.sub.6 alkyl) group, an acylamino group of formula --NHCOC.sub.n H.sub.2n+1 with n from 0 to 6, a group --NH--CSC.sub.n H.sub.2n+1 with n from 0 to 6, a terpenyl group, a cyano group, a C.sub.2 -C.sub.6 alkynyl group, a C.sub.2 -C.sub.6 alkynyl group substituted with a C.sub.1 -C.sub.6 alkyl or an aryl group, a hydroxy (C.sub.1 -C.sub.6 alkyl) group, a (C.sub.1 -C.sub.6 acyl)-oxy(C.sub.1 -C.sub.6 alkyl) group, a (C.sub.1 -C.sub.6 alkyl)thio group and an arylthio group,
- R.sub.2 is chosen from a nitro group, a nitroso group, a thiocyano group, a C.sub.1 -C.sub.6 alkyl group, a C.sub.2 -C.sub.6 alkenyl group, an aryl group, an aryl (C.sub.1 -C.sub.6 alkyl) group, an aryl (C.sub.1 -C.sub.6 alkenyl) group, a carboxyl group, a (C.sub.1 -C.sub.6 alkyl)carbonyl group, an arylcarbonyl group, a (C.sub.1 -C.sub.6 alkoxy)carbonyl group, a (C.sub.1 -C.sub.6 alkoxy)carbonyl(C.sub.1 -C.sub.6 alkyl) group, a trifluoromethyl group, a di(C.sub.1 -C.sub.6 alkyl)amino(C.sub.1 -C.sub.6 alkyl) group, an acylamino group of formula --NHCOC.sub.n H.sub.2n+1 with n from 0 to 6, a group --NH--CSC.sub.n H.sub.2n+1 with n from 0 to 6, a terpenyl group, a cyano group, a C.sub.2 -C.sub.6 alkynyl group, a C.sub.2 -C.sub.6 alkynyl group substituted with a C.sub.1 -C.sub.6 alkyl or an aryl group, a hydroxy (C.sub.1 -C.sub.6 alkyl) group, a (C.sub.1 -C.sub.6 acyl)-oxy(C.sub.1 -C.sub.6 alkyl) group, a (C.sub.1 -C.sub.6 alkyl)thio group and an arylthio group,
- or alternatively R.sub.1 and R.sub.2 together form a mono- or polycyclic C.sub.2 -C.sub.20 alkylene group optionally comprising one or more hetero atoms, with the exception of the 2,2-dimethyltrimethylene group, or a C.sub.3 -C.sub.12 cycloalkylene group.
- 2. A composition according to claim 1 in which R.sub.2 is chosen from C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, aryl, aryl(C.sub.1 -C.sub.6 alkyl), aryl C.sub.2 -C.sub.6 alkenyl, terpenyl, C.sub.2 -C.sub.6 alkynyl, C.sub.2 -C.sub.6 alkynyl substituted with C.sub.1 -C.sub.6 alkyl or aryl.
- 3. A composition according to claim 1 in which R is chose from C.sub.1 -C.sub.6 alkyl.
- 4. Composition according to claim 1, comprising, as active principle, a compound of formula: ##STR23## in which R.sub.1 and R.sub.2 have the meaning given in claim 1.
- 5. Composition according to claim 1, comprising, as active principle, a compound of formula: ##STR24## in which R.sub.1 and R.sub.2 have the meaning given in claim 1 and R.sub.4 represents a C.sub.1 -C.sub.6 alkyl group or an aryl group.
- 6. Composition according to claim 1, comprising, as active principle, a compound of formula: ##STR25## in which R.sub.1 and R.sub.2 have the meaning given in claim 1.
- 7. A method for inhibiting platelet aggregation, comprising administering an amount of a compound according to claim 1, which is effective to inhibit platelet aggregation.
Priority Claims (1)
Number |
Date |
Country |
Kind |
91 05411 |
May 1991 |
FRX |
|
Parent Case Info
This application is a division of pending application Ser. No. 08/140,132, filed Dec. 27, 1993, now U.S. Pat. No. 5,470,871.
Non-Patent Literature Citations (2)
Entry |
Faust, CA 67:82141s (1967). |
Stachel, CA 114:164074a (1991). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
140132 |
Dec 1993 |
|